Telephone
61.8.8209.2666
Address
Salisbury South 1538 Main North Road Salisbury, South Australia (SA) 5106
Description
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 3.74 - 7.31
Trade Value (12mth)
AU$641,811.00
1 week
2.56%
1 month
1.76%
YTD
8.33%
1 year
22.07%
All time high
37.10
EPS 3 yr Growth
-17.50%
EBITDA Margin
-2.40%
Operating Cashflow
-$10m
Free Cash Flow Return
-1.70%
ROIC
-29.20%
Interest Coverage
-2.00
Quick Ratio
1.20
Shares on Issue (Fully Dilluted)
81m
HALO Sector
Healthcare
Next Company Report Date
21-Aug-25
Ex Dividend Date (est.)
18-Jan-23
Next Dividend Pay Date (est.)
27-Jan-23
Reporting Currency
AUD
Short Sell (% of issue)
1.46
Date | Announcements |
---|---|
02 July 25 |
Ceasing to be a substantial holder from MUFG
×
Ceasing to be a substantial holder from MUFG |
01 July 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
27 June 25 |
Becoming a substantial holder from MUFG
×
Becoming a substantial holder from MUFG |
26 June 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
25 June 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
24 June 25 |
Change in substantial holding
×
Change in substantial holding |
20 June 25 |
Ceasing to be a substantial holder from MUFG
×
Ceasing to be a substantial holder from MUFG |
19 June 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
18 June 25 |
Chair's address and presentation at the Scheme Meeting
×
Chair's address and presentation at the Scheme Meeting |
18 June 25 |
Results of Scheme Meeting
×
Results of Scheme Meeting |
17 June 25 |
Ceasing to be a substantial holder from MS
×
Ceasing to be a substantial holder from MS |
17 June 25 |
Change in substantial holding from MUFG
×
Change in substantial holding from MUFG |
16 June 25 |
Update on litigation with Cosette
×
Update on litigation with Cosette |
13 June 25 |
MYX receives further purported notice to terminate SID
×
MYX receives further purported notice to terminate SID |
11 June 25 |
Becoming a substantial holder from MS
×
Becoming a substantial holder from MS |
11 June 25 |
Change in substantial holding from MUFG
×
Change in substantial holding from MUFG |
11 June 25 |
Change in substantial holding
×
Change in substantial holding |
10 June 25 |
Becoming a substantial holder from MUFG
×
Becoming a substantial holder from MUFG |
10 June 25 |
Change in substantial holding
×
Change in substantial holding |
10 June 25 |
Change in substantial holding
×
Change in substantial holding |
10 June 25 |
Change in substantial holding
×
Change in substantial holding |
06 June 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
05 June 25 |
Supplementary Scheme Booklet
×
Supplementary Scheme Booklet |
04 June 25 |
Change in substantial holding
×
Change in substantial holding |
04 June 25 |
Update on Scheme of Arrangement with Cosette
×
Update on Scheme of Arrangement with Cosette |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.